Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVT-1401 (Batoclimab) for Warm Autoimmune Hemolytic Anemia
NCT04253236Phase 2Terminated
- Sponsor
- Immunovant, Inc.
- Start
- Aug 2020
- Primary completion
- Apr 2021
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of batoclimab in warm autoimmune hemolytic anemia (wAIHA), sponsored by Immunovant, Inc.. Started Aug 2020; status: terminated.
02
Drugs
batoclimab
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT04253236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04253236.